144 related articles for article (PubMed ID: 10723133)
1. The p44S10 locus, encoding a subunit of the proteasome regulatory particle, is amplified during progression of cutaneous malignant melanoma.
Ren S; Smith MJ; Louro ID; McKie-Bell P; Bani MR; Wagner M; Zochodne B; Redden DT; Grizzle WE; Wang Nd; Smith DI; Herbst RA; Bardenheuer W; Opalka B; Schütte J; Trent JM; Ben-David Y; Ruppert JM
Oncogene; 2000 Mar; 19(11):1419-27. PubMed ID: 10723133
[TBL] [Abstract][Full Text] [Related]
2. Characterization of two subunits of Arabidopsis 19S proteasome regulatory complex and its possible interaction with the COP9 complex.
Kwok SF; Staub JM; Deng XW
J Mol Biol; 1999 Jan; 285(1):85-95. PubMed ID: 9878390
[TBL] [Abstract][Full Text] [Related]
3. Multiple features of advanced melanoma recapitulated in tumorigenic variants of early stage (radial growth phase) human melanoma cell lines: evidence for a dominant phenotype.
Bani MR; Rak J; Adachi D; Wiltshire R; Trent JM; Kerbel RS; Ben-David Y
Cancer Res; 1996 Jul; 56(13):3075-86. PubMed ID: 8674065
[TBL] [Abstract][Full Text] [Related]
4. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
5. cDNA cloning of p40, a regulatory subunit of the human 26S proteasome, and a homolog of the Mov-34 gene product.
Tsurumi C; DeMartino GN; Slaughter CA; Shimbara N; Tanaka K
Biochem Biophys Res Commun; 1995 May; 210(2):600-8. PubMed ID: 7755639
[TBL] [Abstract][Full Text] [Related]
6. Dominant-negative transcription factor AP-2 augments SB-2 melanoma tumor growth in vivo.
Gershenwald JE; Sumner W; Calderone T; Wang Z; Huang S; Bar-Eli M
Oncogene; 2001 Jun; 20(26):3363-75. PubMed ID: 11423987
[TBL] [Abstract][Full Text] [Related]
7. No evidence for amplification of 25-hydroxyvitamin D-1alpha-OHase (1alpha-OHase) or 1,25-dihydroxyvitamin D-24-OHase (24-OHase) genes in malignant melanoma (MM).
Reichrath J; Rafi L; Rech M; Meineke V; Tilgen W; Seifert M
J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):163-6. PubMed ID: 15225766
[TBL] [Abstract][Full Text] [Related]
8. Functional evidence of novel tumor suppressor genes for cutaneous malignant melanoma.
Parris CN; Harris JD; Griffin DK; Cuthbert AP; Silver AJ; Newbold RF
Cancer Res; 1999 Feb; 59(3):516-20. PubMed ID: 9973191
[TBL] [Abstract][Full Text] [Related]
9. Molecular cloning of the breakpoint region on chromosome 6 in cutaneous malignant melanoma: evidence for deletion in the c-myb locus and translocation of a segment of chromosome 12.
Dasgupta P; Linnenbach AJ; Giaccia AJ; Stamato TD; Reddy EP
Oncogene; 1989 Oct; 4(10):1201-5. PubMed ID: 2677917
[TBL] [Abstract][Full Text] [Related]
10. A malignant melanoma tumor suppressor on human chromosome 11.
Robertson G; Coleman A; Lugo TG
Cancer Res; 1996 Oct; 56(19):4487-92. PubMed ID: 8813145
[TBL] [Abstract][Full Text] [Related]
11. Amplification of MGC2177, PLAG1, PSMC6P, and LYN in a malignant mixed tumor of salivary gland detected by cDNA microarray with tyramide signal amplification.
Tsang YT; Chang YM; Lu X; Rao PH; Lau CC; Wong KK
Cancer Genet Cytogenet; 2004 Jul; 152(2):124-8. PubMed ID: 15262430
[TBL] [Abstract][Full Text] [Related]
12. Tissue and cell distribution of a mammalian proteasomal ATPase, MSS1, and its complex formation with the basal transcription factors.
Yanagi S; Shimbara N; Tamura Ta
Biochem Biophys Res Commun; 2000 Dec; 279(2):568-73. PubMed ID: 11118327
[TBL] [Abstract][Full Text] [Related]
13. Gene expression of the proteasome in rat lens development.
Cai H; Singh I; Wagner BJ
Exp Eye Res; 1998 Mar; 66(3):339-46. PubMed ID: 9533861
[TBL] [Abstract][Full Text] [Related]
14. Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma.
Barks JH; Thompson FH; Taetle R; Yang JM; Stone JF; Wymer JA; Khavari R; Guan XY; Trent JM; Pinkel D; Nelson MA
Genes Chromosomes Cancer; 1997 Aug; 19(4):278-85. PubMed ID: 9258664
[TBL] [Abstract][Full Text] [Related]
15. The mouse Psma1 gene coding for the alpha-type C2 proteasome subunit: structural and functional analysis, mapping, and colocalization with Pde3b on mouse chromosome 7.
Hopitzan A; Himmelbauer H; Spevak W; Castanon MJ
Genomics; 2000 Jun; 66(3):313-23. PubMed ID: 10873386
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic inactivation of RAS association domain family protein 1 (RASSF1A) in malignant cutaneous melanoma.
Spugnardi M; Tommasi S; Dammann R; Pfeifer GP; Hoon DS
Cancer Res; 2003 Apr; 63(7):1639-43. PubMed ID: 12670917
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G
Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905
[TBL] [Abstract][Full Text] [Related]
18. Growth control by tumor suppressors in malignant melanoma.
Coleman A; Robertson G; Lugo TG
Receptor; 1995; 5(1):9-19. PubMed ID: 7613487
[TBL] [Abstract][Full Text] [Related]
19. Rapid isolation and characterization of the yeast proteasome regulatory complex.
Saeki Y; Toh-e A; Yokosawa H
Biochem Biophys Res Commun; 2000 Jul; 273(2):509-15. PubMed ID: 10873636
[TBL] [Abstract][Full Text] [Related]
20. Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation.
Henriksen J; Aagesen TH; Maelandsmo GM; Lothe RA; Myklebost O; Forus A
Oncogene; 2003 Aug; 22(34):5358-61. PubMed ID: 12917637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
